US$ 28.10
tirzepatide as compared with semaglutide for the treatment of obesity vs Tirzepatide: Which GLP-1 Wins Weight Loss? Semaglutide vs Tirzepatide for Weight
Description
Safely inject Semaglutide with our detailed guide

For years, GLP-1 medication has transformed conversations around weight loss but left many virtually locked out by costs

Active-treatment exposure totaled 51,346 patient-years, including 47,749 patient-years for semaglutide and 3,598 patient-years for tirzepatide

Look at the incretin/GLP-1 story as a mechanism class, not as isolated products: Ozempic reached $1B in 3 years

Tirzepatide is a novel, once-weekly, dual GIP and GLP-1 receptor agonist (twincretin) for the treatment of type 2 diabetes